Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
Huang L, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang HC, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, Jiang Z, Wang H, Lamour F, Song G, Curran M, Duan C, Lysbet de Haas S, Restuccia E, Shao Z.
Huang L, et al. Among authors: wang h, wang hc, wang y, wang s, wang c.
Nat Commun. 2024 Mar 9;15(1):2153. doi: 10.1038/s41467-024-45591-7.
Nat Commun. 2024.
PMID: 38461323
Free PMC article.
Clinical Trial.